CDC seeks to continue data collection for study of CRC screening indirect costs

In 2013, the Centers for Disease Control and Prevention began to conduct a study to measure the patient time and costs associated with colorectal cancer screening colonoscopy and fecal immunochemical tests, according to an insurancenewsnet report.

Advertisement

 

The project, Colorectal Cancer Control Program Indirect/Non-Medical Cost Study (OMB No. 0920-0963, exp. 4/30/2014), received Office of Management and Budget approval, but the desired amount of information was not gathered during the initial approval period, according to the report.

The CDC is requesting a year-long extension from the OMB to collect and analyze the target amount of data.

More Articles on Gastroenterology:
Physicians at the helm: creating a culture of gastroenterologist leadership in ASCs & endoscopy centers
7 gastroenterologists making the news
Boston Scientific reports $1.87B in Q2 sales: 5 financial report highlights

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.